BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; and oral diabetic drugs.BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
Frequently asked questions
What sector does Bioton S.A. (BIO) operate in?
Bioton S.A. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Bioton S.A. (BIO) current stock price?
As of the latest data, Bioton S.A. stock price is PLN 3.84, with a previous close of PLN 3.84.
What is Bioton S.A. (BIO) current market capitalization?
Bioton S.A. market cap is approximately 329.72 million.
What is Bioton S.A. (BIO) Earnings Per Share (EPS)?
The trailing EPS is PLN 0.05.
What is Bioton S.A. (BIO) Price-to-Earnings (P/E) ratio?
Bioton S.A. current P/E ratio is 76.8.
What is Bioton S.A. (BIO) EBITDA?
Bioton S.A. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.06 million.
Does Bioton S.A. (BIO) pay dividends?
No. Bioton S.A. does not pay a dividend.
What is Bioton S.A. (BIO) beta (volatility) score?
Bioton S.A. has a beta of 0.173, indicating lower volatility than the overall market.